Roche

2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
Yahoo/Reuters
Thu, 05/11/23 - 10:08 am
BioNTech
Roche
Genentech
pancreatic cancer
MRNA
Nature
vaccines
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
BioSpace
Wed, 05/10/23 - 10:18 am
Gilead Sciences
GSK
momelotinib
Roche
Eli Lilly
lebrikizumab
Merck
Zejula
Amgen
Galenica
Veltassa
Cubicin
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
AbbVie
Amgen
AstraZeneca
Bristol Myers Squibb
Daiichi Sankyo
Eli Lilly
Gilead Sciences
Horizon Therapeutics
Merck
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
BioSpace
Tue, 05/9/23 - 12:27 pm
Roche
Genentech
FDA
Vabysmo
macular edema
retinal vein occlusion
Roche, with HER2 franchise under pressure, pays $70M for breast cancer brain metastases prospect
Fierce Biotech
Tue, 05/9/23 - 11:39 am
Roche
Zion Pharma
brain metastases
breast cancer
Iteos – and GSK – keep the faith
EP Vantage
Tue, 05/9/23 - 10:40 am
GSK
iTeos Therapeutics
anti-TIGIT
Roche
belrestotug
Roche opens new institute to advance research in human model systems
Pharmaceutical Technology
Thu, 05/4/23 - 09:26 am
Roche
R&D
organoids
Switzerland
'More in the hopper': European Big Pharmas hint M&A could ramp up
Fierce Biotech
Mon, 05/1/23 - 10:15 am
Europe
M&A
GSK
Novartis
Roche
Go or no go? Sarepta’s gene therapy faces scrutiny
EP Vantage
Thu, 04/27/23 - 10:29 am
Sarepta Therapeutics
gene therapy
SRP-9001
Roche
DMD
Duchenne Muscular Dystrophy
Roche’s new eye drug pressures Eylea with strong launch
BioPharma Dive
Wed, 04/26/23 - 05:44 pm
Roche
Vabysmo
Eylea
earnings
Regeneron
Roche nixes Tecentriq trial in early breast cancer, but it's 'still in the game' in key lung cancer use: exec
Fierce Pharma
Wed, 04/26/23 - 10:12 am
Roche
Tecentriq
breast cancer
Teresa Graham
Pharma CEOs
Roche, seeing MAGE magic wane, makes pair of solid tumor bispecifics disappear
Fierce Biotech
Wed, 04/26/23 - 10:08 am
Roche
earnings
solid tumors
MAGE-A4
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Amgen
Regeneron Pharmaceuticals
Sanofi
Supreme Court
patents
Pfizer
Bayer
Roche
Genentech
AstraZeneca
JNJ
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
R&D
AbbVie
Amgen
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
GSK
JNJ
Merck
Merck KGaA
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
UCB
Vertex Pharmaceuticals
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
M&A
R&D
AbbVie
AstraZeneca
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
FDA Green Lights Roche's Polivy in First-Line DLBCL
BioSpace
Thu, 04/20/23 - 10:45 am
Roche
Genentech
Polivy
diffuse large B-cell lymphoma
FDA
AACR: Patient deaths taint Roche's industry-first early-stage liver cancer readout for Tecentriq and Avastin
Fierce Pharma
Sun, 04/16/23 - 11:26 pm
Roche
AACR
liver cancer
patient deaths
Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
Tue, 04/11/23 - 07:18 pm
layoffs
biotech
Amgen
Pfizer
Roche
Jounce Therapeutics
Fate Therapeutics
Molecular Templates
Sorrento Therapeutics
Genexine's anemia drug matches Roche-CSL product in phase 3, laying groundwork for Asia filings
Fierce Biotech
Tue, 04/11/23 - 10:07 am
Genexine
chronic kidney disease
anemia
Roche
CSL Vifor
Mircera

Pages